The AltaValve transcatheter mitral valve replacement (TMVR) system had sustained effects among patients with severe mitral ...

Atrial fibrillation (AF) was present in 1 in 6 patients with chronic aortic regurgitation — either moderate-to-severe or severe — and was independently associated with an increased risk for mortality ...

Infection with syphilis is associated with an increased risk for several major adverse cardiovascular outcomes and death.

Tricuspid regurgitation (TR) is common in patients with atrial functional mitral regurgitation (AFMR). However, very few studies have explored its clinical characteristics, determinants, and ...

A new study found that older patients with atrial functional mitral regurgitation who underwent mitral valve surgery had significantly better outcomes than those who received medical management alone, ...

Syphilis is independently linked to an elevated risk for major cardiovascular events and death, with the strongest ...

Aortic insufficiency occurs when your aortic valve fails to close properly once the blood enters the aorta. This causes blood to flow the wrong way back into the heart. When the left ventricle doesn’t ...

SAN FRANCISCO -- Aortic valve regurgitation treated with the investigational JenaValve Trilogy appeared safe and effective in the ALIGN AR trial. The device met the safety benchmark, with a 26.7% rate ...

NEW YORK, NY—For patients with pure native aortic regurgitation (AR) who are undergoing TAVI, use of devices tailored to treat the AR seems to provide superior outcomes compared with off-label use of ...

However, aortic regurgitation (AR) remains an "off-label" indication for TAVR, particularly for patients with mild or absent leaflet calcification or aortic annulus dimensions beyond the size of the ...

The FDA has granted pre-market approval to JenaValve’s Trilogy system, the first transcatheter aortic valve replacement (TAVR) device in the U.S. specifically indicated for severe aortic regurgitation ...